Revuforj

Active Ingredient(s): Revumenib Citrate
FDA Approved: * November 15, 2024
Pharm Company: * SYNDAX
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Revuforj 25 mg Oral Tablet, Film Coated
NDC: 73555-500
Labeler:
Syndax Pharmaceuticals, Inc.
Revuforj 110 mg Oral Tablet, Film Coated
NDC: 73555-501
Labeler:
Syndax Pharmaceuticals, Inc.
Revuforj 160 mg Oral Tablet, Film Coated
NDC: 73555-502
Labeler:
Syndax Pharmaceuticals, Inc.